Mal-Phe-C4-VC-PAB-DMEA-PNU-159682 Catalog No.:M31069-C InChi: InChI=1S/C30H34N2O6/c1-36-29-13-24(8-9-28(29)38-18-20-2-4-22(5-3-20)23-6-7-23)25-14-32(15-25)30(35)27-12-21(10-11-31-27)17-37-19-26(34)16-33/h2-5

InChi: InChI=1S/C30H34N2O6/c1-36-29-13-24(8-9-28(29)38-18-20-2-4-22(5-3-20)23-6-7-23)25-14-32(15-25)30(35)27-12-21(10-11-31-27)17-37-19-26(34)16-33/h2-5

Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL

Chemical Name: (R)-1-(2-((S)-7-fluoro-3-(trifluoromethyl)-2

human lymphocyte L-selectin shedding

6)16-19/h8-14

Mal-Phe-C4-VC-PAB-DMEA-PNU-159682 Catalog No.:M31069-C InChi: InChI=1S/C30H34N2O6/c1-36-29-13-24(8-9-28(29)38-18-20-2-4-22(5-3-20)23-6-7-23)25-14-32(15-25)30(35)27-12-21(10-11-31-27)17-37-19-26(34)16-33/h2-5Mal Phe C4 VC PAB DMEA PNU 159682, a drug linker conjugate for ADC, consists the ADC linker Mal Phe C4 VC PAB and a potent ADC cytotoxin DMEA PNU 159682. DMEA PNU 159682 includes metabolites of nemorubicin (MMDX) from liver microsomes and ADC cytotoxin PNU 159682. Product information CAS Number: 2259318 54 0 Molecular Weight: 1402. 46 Formula: C70H83N9O22 Chemical Name: {4 [(2S) 5 (carbamoylamino) 2 [(2S) 2 {4 [4 (2,5 dioxo 2,5 dihydro 1H pyrrol 1